▶ 調査レポート

睡眠時無呼吸症候群の世界市場:診断装置別、治療装置別、地域別分析

• 英文タイトル:Global Sleep Apnea Market - Segmented by Diagnostic Devices, by Therapeutic Devices, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。睡眠時無呼吸症候群の世界市場:診断装置別、治療装置別、地域別分析 / Global Sleep Apnea Market - Segmented by Diagnostic Devices, by Therapeutic Devices, and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-05378資料のイメージです。• レポートコード:B-MOR-05378
• 出版社/出版日:Mordor Intelligence / 2018年3月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、睡眠時無呼吸症候群の世界市場について調べ、睡眠時無呼吸症候群の世界規模、市場動向、市場環境、診断装置別分析、治療装置別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・睡眠時無呼吸症候群の世界市場インサイト
・睡眠時無呼吸症候群の世界市場環境
・睡眠時無呼吸症候群の世界市場動向
・睡眠時無呼吸症候群の世界市場規模
・睡眠時無呼吸症候群の世界市場規模:診断装置別
・睡眠時無呼吸症候群の世界市場規模:治療装置別
・睡眠時無呼吸症候群の世界市場:地域別市場規模・分析
・睡眠時無呼吸症候群の北米市場規模・予測
・睡眠時無呼吸症候群のアメリカ市場規模・予測
・睡眠時無呼吸症候群のヨーロッパ市場規模・予測
・睡眠時無呼吸症候群のアジア市場規模・予測
・睡眠時無呼吸症候群の日本市場規模・予測
・睡眠時無呼吸症候群の中国市場規模・予測
・睡眠時無呼吸症候群のインド市場規模・予測
・睡眠時無呼吸症候群の韓国市場規模・予測
・関連企業情報・競争状況

The sleep apnea market is expected to witness a CAGR of 7.5% during the forecast period. North America dominates the global market due to the high incidence of Sleep-Disordered Breathing (SDB) in the USA.

Increasing Incidence of Sleep Apnea

It has been observed that one in every five adults have mild obstructive sleep apnea (OSA) and one in fifteen adults have moderate to severe obstructive sleep apnea (OSA). It has also been detected that 9% of middle-aged women and 25% of middle-aged men suffer from OSA, while 75% of severe sleep-disordered breathing (SDB) cases remain undiagnosed. The number of OSA patients is increasing with the aging population and growing levels of obesity. The prevalence of OSA is approximately 3% to 7% in adult men and 2% to 5% in adult women, in the general population. Additionally, up to 50% of the adult population are snorers, which is an indicator of the presence of OSA and a significant social problem. Thus, increasing incidence of the sleep apnea is fuelling the growth of the sleep apnea devices market.
Additionally, increasing awareness among the patient population in developing countries, favorable government initiatives, and upcoming technological advancements, are also driving the sleep apnea devices market.

High Cost of Devices

A sleep apnea diagnosis is usually based on sleep history and the results of a polysomnogram, an overnight sleep study that typically costs about $1,000-$3,000. The healthcare cost and utilization project put the average cost of operations on the nose, throat or mouth, at USD 10,219. Thus, high cost of these sleep devices is hindering the growth of the global sleep apnea devices market.
Additionally, availability of alternate methods for sleep apnea, is also restraining the growth of the global sleep apnea device market.

Europe Expected to Grow at High CAGR

North America dominates the global market due to the high incidence of sleep-disordered breathing (SDB) in the United States. The European region is projected to register the highest CAGR during the forecast period, due to the use of noninvasive and painless cardiorespiratory monitors that are used to assess the oxygen saturation level of arterial blood.

Key Developments in the Market

• January 2018: ResMed joined MedTech Europe, to make innovative medical technology and health solutions that are available to people
• November 2017: SleepScore Labs launched advanced sleep improvement system

Major Players: CADWELL LABORATORIES INC., CAREFUSION CORPORATION, FISHER & PAYKEL HEALTHCARE LIMITED, GE HEALTHCARE, INVACARE CORPORATION, NATUS MEDICAL INCORPORATED, NIHON KOHDEN CORPORATION, PHILIPS HEALTHCARE, RESMED and TELEFLEX INCORPORATED amongst others.

Reasons to Purchase the Report

• Current and future market outlook for sleep apnea devices, in the developed and emerging markets
• Analyze various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Driver
6.1.1 Increasing Incidences of Sleep Apnea
6.1.2 Increasing Awareness among the Patient Population in Developing Countries
6.1.3 Favorable Government Initiatives
6.1.4 Upcoming Technological Advancements
6.2 Market Restraints
6.2.1 High Cost of devices
6.2.2 Availability of Alternate Methods
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Diagnostic Devices
7.1.1 Polysomnography Devices (PSG)
7.1.2 Pulse Oximeters
7.1.3 Actigraphy Devices
7.2 By Therapeutic Devices
7.2.1 Positive Airway Pressure (PAP) Devices
7.2.1.1 Continuous Positive Airway Pressure (CPAP) Devices
7.2.1.2 Bi-level Positive Airway Pressure (BiPAP) Devices
7.2.2 Oxygen Devices
7.2.2.1 Oxygen Concentrators
7.2.2.2 Portable Oxygen Concentrators
7.2.2.3 Liquid Portable Oxygen
7.2.3 Oral Appliances
7.2.4 Adaptive Servo Ventilation (ASV) Devices
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia
7.3.3.5 New Zealand
7.3.3.6 South Korea
7.3.3.7 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations and Partnerships
8.3 New Product Launches
9. Key Players
9.1 Cadwell Laboratories Inc.
9.2 CareFusion Corporation
9.3 Fisher & Paykel Healthcare Limited
9.4 GE Healthcare
9.5 Invacare Corporation
9.6 Natus Medical Incorporated
9.7 Nihon Kohden Corporation
9.8 Philips Healthcare
9.9 Resmed
9.10 Teleflex Incorporated
10. Future of the Market